Paul Knaapen

Showing 1-6 of 6 articles

Coronary interventions

Association between Coronary Collaterals and Myocardial Viability in Patients with a Chronic Total Occlusion

Schumacher S, Everaars H, Stuijfzand W, Huynh J, van Diemen P, Bom M, de Winter R, van Loon R, van de Ven P, van Rossum A, Opolski M, Nap A, Knaapen P

March 3, 2020 | 10.4244/EIJ-D-19-01006

Coronary interventions

Relationship between Extent of Ischaemic Burden and Changes in Absolute Myocardial Perfusion after Chronic Total Occlusion Percutaneous Coronary Intervention

Schumacher S, Kockx M, Stuijfzand W, Driessen R, van Diemen P, Bom M, Everaars H, Raijmakers P, Boellaard R, van Rossum A, Opolski M, Nap A, Knaapen P

September 24, 2019 | 10.4244/EIJ-D-19-00631

Coronary interventions

Comprehensive physiological evaluation of epicardial and microvascular coronary domains using vascular conductance and zero flow pressure

van der Hoeven NW, de Waard G, Quirós A, de Hoyos A, Broyd C, Nijjer S, van de Hoef T, Petraco R, Driessen R, Mejía-Rentería H, Kikuta Y, Pinto M, van de Ven P, Meuwissen M, Knaapen P, Piek J, Davies J, van Royen N, Escaned J

February 7, 2019 | 10.4244/EIJ-D-18-00021

Coronary interventions

Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function

Stuijfzand W, Biesbroek P, Raijmakers P, Driessen R, Schumacher S, van Diemen P, van den Berg J, Nijveldt R, Lammertsma A, Walsh S, Hanratty C, Spratt J, van Rossum A, Nap A, van Royen N, Knaapen P

June 20, 2017 | 10.4244/EIJ-D-16-01014

Coronary interventions

Non-invasive assessment of the collateral circulation in the hand: validation of the Nexfin system and relation to clinical outcome after transradial catheterisation

Hollander M, van Leeuwen M, van der Heijden D, Keizer V, van de Ven P, IJsselmuiden S, Van Mieghem N, Amoroso G, Ritt M, Knaapen P, van Royen N

February 20, 2017 | 10.4244/EIJ-D-16-00337

Coronary interventions

Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial

Stuijfzand W, Raijmakers P, Driessen R, Lammertsma A, van Rossum A, Nap A, Appelman Y, Lemkes J, van Leeuwen M, van Royen N, Knaapen P

August 5, 2016 | 10.4244/EIJV12I5A98

1

Latest news

Atherectomies, in-stent restenosis, stent thrombosis, coronary physiology in TAVI and heart failure

Ahead of print: New technique of percutaneous mitral valvuloplasty

C. Aurigemma et al

Rotational atherectomy and the myth of Sisyphus

Guidance Papers

Guidelines, consensus & position papers

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

Fractional flow reserve substitutes in aortic stenosis

Nils P. Johnson

This Week's JAA's: Coronary Artery Thrombosis, Maveric Trial...

Valvular disease